BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10606166)

  • 1. Clinical utility in maximizing CD34+ cell count in stem cell grafts.
    Burt RK
    Stem Cells; 1999; 17(6):373-6. PubMed ID: 10606166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pluripotent and myeloid-committed CD34+ subsets in hematopoietic stem cell allografts.
    Theilgaard-Mönch K; Raaschou-Jensen K; Schjødt K; Heilmann C; Vindeløv L; Jacobsen N; Dickmeiss E
    Bone Marrow Transplant; 2003 Dec; 32(12):1125-33. PubMed ID: 14647266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.
    Astori G; Malangone W; Adami V; Risso A; Dorotea L; Falasca E; Marini L; Spizzo R; Bigi L; Sala P; Tonutti E; Biffoni F; Rinaldi C; Del Frate G; Pittino M; Degrassi A
    Blood Cells Mol Dis; 2001; 27(4):715-24; discussion 725-7. PubMed ID: 11778655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility in maximizing CD34+ cell count in stem cell grafts.
    Burt RK
    Oncologist; 1999; 4(3):265-8. PubMed ID: 10394595
    [No Abstract]   [Full Text] [Related]  

  • 5. Absence of a CD34- hematopoietic precursor population in recipients of CD34+ stem cell transplantation.
    Kato S; Ando K; Nakamura Y; Muguruma Y; Sato T; Yabe H; Yabe M; Hattori K; Yasuda Y; Hotta T
    Bone Marrow Transplant; 2001 Sep; 28(6):587-95. PubMed ID: 11607772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Australasian CD34+ quality assurance program and rationale for the clinical utility of the single-platform method for CD34+ cell enumeration.
    Chang A; Raik E; Marsden K; Ma DD
    Cytotherapy; 2004; 6(1):50-61. PubMed ID: 14985167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engraftment syndrome after autologous peripheral blood stem cell transplantation with high numbers of peripheral blood stem cells followed by granulocyte colony-stimulating factor administration.
    Kawano C; Muroi K; Kuribara R; Matsumoto Y; Ohtsuki T; Hatake K; Ozawa K
    Bone Marrow Transplant; 2000 Jan; 25(2):228-9. PubMed ID: 10673691
    [No Abstract]   [Full Text] [Related]  

  • 8. Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts.
    Theilgaard-Mönch K; Raaschou-Jensen K; Palm H; Schjødt K; Heilmann C; Vindeløv L; Jacobsen N; Dickmeiss E
    Bone Marrow Transplant; 2001 Dec; 28(11):1073-82. PubMed ID: 11781619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A contribution to a study of apoptosis of hematopoietic stem cells CD34+ by flow cytometry before and after cryopreservation].
    Ben Nasr M; Jenhani F
    Transfus Clin Biol; 2008 Jun; 15(3):91-7. PubMed ID: 18619889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial DNA sequence heterogeneity of single CD34+ cells after nonmyeloablative allogeneic stem cell transplantation.
    Yao YG; Childs RW; Kajigaya S; McCoy JP; Young NS
    Stem Cells; 2007 Oct; 25(10):2670-6. PubMed ID: 17628021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation.
    Allan DS; Keeney M; Howson-Jan K; Popma J; Weir K; Bhatia M; Sutherland DR; Chin-Yee IH
    Bone Marrow Transplant; 2002 Jun; 29(12):967-72. PubMed ID: 12098064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
    Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
    Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood.
    Meyer TP; Hofmann B; Zaisserer J; Jacobs VR; Fuchs B; Rapp S; Weinauer F; Burkhart J
    Cytotherapy; 2006; 8(3):265-76. PubMed ID: 16793735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive early apoptosis in frozen-thawed CD34-positive stem cells decreases threshold doses for haematological recovery after autologous peripheral blood progenitor cell transplantation.
    de Boer F; Dräger AM; Pinedo HM; Kessler FL; van der Wall E; Jonkhoff AR; van der Lelie J; Huijgens PC; Ossenkoppele GJ; Schuurhuis GJ
    Bone Marrow Transplant; 2002 Feb; 29(3):249-55. PubMed ID: 11859398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
    Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
    Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Techniques of positive isolation of CD34(+) cells. Personal experience with the immunomagnetic method].
    Markiewicz M; Kamińska H; Wojnar J; Jagoda K; Krawczyk M; Hołowiecki J
    Acta Haematol Pol; 1996; 27(1):57-63. PubMed ID: 8629445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA; Sims-Poston L; Eldridge P; Hale GA
    Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the CD34+ 38- cells in posttransplant hematopoietic recovery.
    Hénon P; Sovalat H; Bourderont D; Ojeda-Uribe M; Arkam Y; Wunder E; Raidot JP; Husseini F; Audhuy B
    Stem Cells; 1998; 16 Suppl 1():113-22. PubMed ID: 11012153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of phenotypes and kinetics of CD34+ cells and lymphocytes in donors of hematopoietic stem cells for allogenic transplantation].
    Klabusay M; Suková V; Korístek Z; Mayer J; Vorlícek J
    Cas Lek Cesk; 2003; 142(7):410-6. PubMed ID: 14515444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure to achieve a threshold dose of CD34+ CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation.
    Sartor MM; Garvin F; Antonenas V; Bradstock KF; Gottlieb DJ
    Bone Marrow Transplant; 2007 Nov; 40(9):851-7. PubMed ID: 17704793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.